Intestine-specific deletion of acyl-CoA:monoacylglycerol acyltransferase (MGAT) 2 protects mice from diet-induced obesity and glucose intolerance

J Biol Chem. 2014 Jun 20;289(25):17338-49. doi: 10.1074/jbc.M114.555961. Epub 2014 May 1.

Abstract

The absorption of dietary fat involves the re-esterification of digested triacylglycerol in the enterocytes, a process catalyzed by acyl-CoA:monoacylglycerol acyltransferase (MGAT) 2. Mice without a functional gene encoding MGAT2 (Mogat2(-/-)) are protected from diet-induced obesity. Surprisingly, these mice absorb normal amounts of dietary fat but increase their energy expenditure. MGAT2 is expressed in tissues besides intestine, including adipose tissue in both mice and humans. To test the hypothesis that intestinal MGAT2 regulates systemic energy balance, we generated and characterized mice deficient in MGAT2 specifically in the small intestine (Mogat2(IKO)). We found that, like Mogat2(-/-) mice, Mogat2(IKO) mice also showed a delay in fat absorption, a decrease in food intake, and a propensity to use fatty acids as fuel when first exposed to a high fat diet. Mogat2(IKO) mice increased energy expenditure although to a lesser degree than Mogat2(-/-) mice and were protected against diet-induced weight gain and associated comorbidities, including hepatic steatosis, hypercholesterolemia, and glucose intolerance. These findings illustrate that intestinal lipid metabolism plays a crucial role in the regulation of systemic energy balance and may be a feasible intervention target. In addition, they suggest that MGAT activity in extraintestinal tissues may also modulate energy metabolism.

Keywords: Diacylglycerol; Diet; Energy Metabolism; Lipid Absorption; Triacylglycerol.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Dietary Fats / adverse effects*
  • Dietary Fats / pharmacology
  • Eating / genetics
  • Energy Metabolism / drug effects
  • Energy Metabolism / genetics
  • Fatty Liver / enzymology
  • Fatty Liver / genetics
  • Fatty Liver / pathology
  • Fatty Liver / prevention & control
  • Gene Deletion
  • Glucose Intolerance / enzymology*
  • Glucose Intolerance / genetics
  • Glucose Intolerance / pathology
  • Glucose Intolerance / prevention & control
  • Humans
  • Hypercholesterolemia / enzymology
  • Hypercholesterolemia / genetics
  • Hypercholesterolemia / pathology
  • Hypercholesterolemia / prevention & control
  • Intestinal Absorption / drug effects
  • Intestinal Absorption / genetics
  • Intestines / enzymology*
  • Intestines / pathology
  • Mice
  • Mice, Knockout
  • N-Acetylglucosaminyltransferases / genetics
  • N-Acetylglucosaminyltransferases / metabolism*
  • Obesity / chemically induced
  • Obesity / enzymology*
  • Obesity / genetics
  • Obesity / pathology
  • Obesity / prevention & control

Substances

  • Dietary Fats
  • N-Acetylglucosaminyltransferases
  • alpha-1,6-mannosyl-glycoprotein beta-1,2-N-acetylglucosaminyltransferase